company background image
1066 logo

Shandong Weigao Group Medical Polymer SZSC:1066 Stock Report

Last Price

HK$4.59

Market Cap

HK$21.0b

7D

0%

1Y

-38.8%

Updated

24 Dec, 2024

Data

Company Financials +

Shandong Weigao Group Medical Polymer Company Limited

SZSC:1066 Stock Report

Market Cap: HK$21.0b

1066 Stock Overview

Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. More details

1066 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends4/6

My Notes

Capture your thoughts, links and company narrative

Shandong Weigao Group Medical Polymer Company Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Shandong Weigao Group Medical Polymer
Historical stock prices
Current Share PriceHK$4.59
52 Week HighHK$7.70
52 Week LowHK$3.60
Beta0.46
1 Month Change4.32%
3 Month Change-4.77%
1 Year Change-38.80%
3 Year Change-53.26%
5 Year Change-50.86%
Change since IPO-11.56%

Recent News & Updates

Recent updates

Shareholder Returns

1066HK Medical EquipmentHK Market
7D0%2.4%2.3%
1Y-38.8%-26.0%22.4%

Return vs Industry: 1066 underperformed the Hong Kong Medical Equipment industry which returned -26.9% over the past year.

Return vs Market: 1066 underperformed the Hong Kong Market which returned 21.1% over the past year.

Price Volatility

Is 1066's price volatile compared to industry and market?
1066 volatility
1066 Average Weekly Movement7.1%
Medical Equipment Industry Average Movement9.0%
Market Average Movement8.8%
10% most volatile stocks in HK Market18.5%
10% least volatile stocks in HK Market4.0%

Stable Share Price: 1066 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 1066's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200012,606Rinan Congwww.weigaogroup.com

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for pre-pack medication and medical needles which mainly include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles; orthopedic materials and instruments, including trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers and related consumables.

Shandong Weigao Group Medical Polymer Company Limited Fundamentals Summary

How do Shandong Weigao Group Medical Polymer's earnings and revenue compare to its market cap?
1066 fundamental statistics
Market capHK$20.98b
Earnings (TTM)HK$2.04b
Revenue (TTM)HK$13.80b

10.3x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1066 income statement (TTM)
RevenueCN¥12.97b
Cost of RevenueCN¥6.52b
Gross ProfitCN¥6.44b
Other ExpensesCN¥4.53b
EarningsCN¥1.91b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.42
Gross Margin49.69%
Net Profit Margin14.74%
Debt/Equity Ratio16.3%

How did 1066 perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

44%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 16:14
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Weigao Group Medical Polymer Company Limited is covered by 35 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason MannBarclays
Derrick SunBNP Paribas Securities (Asia)
Feng Qiang SunBOCOM International Securities Limited